Do Analysts Expect Aptose Biosciences Inc (APTO) Stock to Rise After It Is Lower By -6.56% in a Month?

Friday, April 22, 2022 10:56 AM | InvestorsObserver Analysts

Mentioned in this article

Wall Street is positive on Aptose Biosciences Inc (APTO). On average, analysts give APTO a Strong Buy rating. The average price target is $8.5, which means analysts expect the stock to rise by 645.61% over the next twelve months. That average ranking earns APTO an Analyst Rating of 73, which is better than 73% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating APTO a Strong Buy today. Find out what this means to you and get the rest of the rankings on APTO!
See Full APTO Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Aptose Biosciences Inc Stock Today?

Aptose Biosciences Inc (APTO) stock is up 1.79% while the S&P 500 is down -1.2% as of 10:54 AM on Friday, Apr 22. APTO has risen $0.02 from the previous closing price of $1.12 on volume of 45,204 shares. Over the past year the S&P 500 is higher by 4.98% while APTO is down -77.38%. APTO lost -$0.73 per share the over the last 12 months. Click Here to get the full Stock Report for Aptose Biosciences Inc stock.

Share this article:

Related Articles